• 1. An Appraisal of pH triggered Bacitracin drug release, through composite hydrogel systems
  RabailGul,MariamMir,MurtazaNAli
• 2. Aggregation-induced emission enhancement of carbon quantum dots and applications in light emitting devices
  Rongyan Guo,Tao Li,Shuie Shi J. Mater. Chem. C, 2019,7, 5148-5154
• 3. Aggregation of biologically important peptides and proteins: inhibition or acceleration depending on protein and metal ion concentrations
  Benjamin Gabriel Poulson,Kacper Szczepski,Joanna Izabela Lachowicz,Lukasz Jaremko,Abdul-Hamid Emwas,Mariusz Jaremko RSC Adv., 2020,10, 215-227
• 4. An approach to C–N activation: coupling of arenesulfonyl hydrazides and arenesulfonyl chlorides with tert-amines via a metal-, oxidant- and halogen-free anodic oxidation??
  M. Sheykhan,S. Khani,S. Shaabanzadeh,M. Joafshan Green Chem., 2017,19, 5940-5948
• 5. Alumina grafted SBA-15 sustainable bifunctional catalysts for direct cross-coupling of benzylic alcohols to diarylmethanes?
  Chandran Rajendran,Govindaswamy Satishkumar,Charlotte Lang,Eric M. Gaigneaux Catal. Sci. Technol., 2020,10, 2583-2592

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Methanone, (4-Fluorophenyl)-3-Pyridinyl: A Comprehensive Overview

Methanone, (4-fluorophenyl)-3-pyridinyl- is a unique organic compound characterized by its combination of a ketone group and fused aromatic rings. With the CAS registry number 52779-56-3, this compound has garnered significant attention in the field of biomedical research due to its potential applications in drug discovery and development. This article delves into the structure, synthesis, biological activity, and current research trends surrounding this intriguing molecule.

The molecular framework of Methanone, (4-fluorophenyl)-3-pyridinyl- comprises a ketone functional group attached to a pyridine ring at the 3-position and a fluorobenzene moiety. This fused structure not only imparts unique electronic properties but also renders the compound amenable to various chemical reactions, making it a valuable building block in organic synthesis.

Recent studies have highlighted the potential of Methanone, (4-fluorophenyl)-3-pyridinyl- as a lead compound in the development of kinase inhibitors. These enzymes play pivotal roles in cellular signaling pathways, and their modulation is a promising strategy for treating diseases such as cancer and inflammatory disorders. The fluorine atom in the benzene ring contributes to the compound's lipophilicity, enhancing its ability to cross biological membranes and interact with target proteins.

Another area of active research involving this compound is its application in antibiotic development. The combination of aromatic rings and a ketone group creates a scaffold that can be further functionalized to yield potent antimicrobial agents. This has been explored extensively in the context of combating multi-drug resistant bacterial strains, a pressing global health concern.

Advances in synthetic chemistry have facilitated the large-scale production of Methanone, (4-fluorophenyl)-3-pyridinyl-. Various methods, including Friedel-Crafts alkylation and nucleophilic aromatic substitution, have been employed to achieve high yields. These processes are optimized for cost-efficiency and environmental sustainability, aligning with modern pharmaceutical industry standards.

In the realm of neurodegenerative diseases, this compound has shown promise as a potential therapeutic agent. Its ability to modulate neurotransmitter systems makes it a candidate for the treatment of conditions such as Alzheimer's disease and Parkinson's disease. Ongoing preclinical trials aim to elucidate its efficacy and safety profile further.

Moreover, Methanone, (4-fluorophenyl)-3-pyridinyl- has been explored for its role in oncology. Its influence on cell proliferation and apoptosis pathways positions it as a potential anticancer agent. Collaborative efforts between academic institutions and pharmaceutical companies are driving the translation of these findings into clinical applications.

The structural versatility of Methanone, (4-fluorophenyl)-3-pyridinyl- extends beyond its direct pharmacological applications. It serves as a valuable intermediate in the synthesis of more complex molecules, including those with potential use in imaging agents and contrast media.

As biomedical research continues to advance, the role of Methanone, (4-fluorophenyl)-3-pyridinyl- is likely to expand. Its unique combination of structural features and biological activity positions it as a key player in the development of next-generation therapeutics. By leveraging cutting-edge technologies and interdisciplinary approaches, scientists are poised to unlock new possibilities for this remarkable compound.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)